Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 September 2023 | Story Nicole Bongo | Photo Supplied
GBV dialogue 2023
The UFS Xhosa Student Association and Gender Equality and Anti-Discrimination Office joined forces to host a dialogue to enlighten students on combating gender-based violence.

The Xhosa Student Association at the University of the Free State (UFS), along with the UFS Gender Equality and Anti-Discrimination Office (GEADO) on its Bloemfontein Campus, recently hosted a dialogue titled ‘Aiding the Victim’, to educate students about what perpetuates gender-based violence, and inform them about UFS support services available to help fight GBV.

The discussion was held at the Education Auditorium on 25 August 2023, and students were challenged to pinpoint what GBV is and what it looks like. Balisa Nqambuza, Chairperson of the Xhosa Student Association and second-year BA student majoring in psychology and philosophy, said, “There is a need to have these tough conversations, as they provide insight on how to combat GBV in the future... We have had enough talks about the problem, and it is very important to start speaking about solutions that inform people of what they can do when encountering GBV.” 

The event organisers said the dialogue was an opportunity for GEADO and the Xhosa Student Association to inform students about support structures within the university that provide help for students through free counselling sessions.

“The objective was to bring awareness about GBV victims amongst us, and how to assist them better, and to also highlight comprehensive approaches, as dialogues may discuss holistic approaches that address the multidimensional impact of GBV, including psychological, emotional, physical, and economic consequences,” said Pebetsi Kgole, a guest speaker and intern from GEADO.

In May 2023, the United Nations International Children's Emergency Fund reported a shocking rise in violence against women in South Africa, with 969 murders and 1 485 attempted murders recorded over this period. The UFS has put many structures in place to help in the fight against the scourge of GBV. 

Other support services available include a sexual offense response team made up of GEADO, Protection Services, Kovsie Health, access to psychologists and social workers, and free services to help victims feel safe in a secure environment. 

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept